HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of therapeutic plasma exchanges in refractory severe warm autoimmune hemolytic anemia: Presentation of two case reports.

AbstractBACKGROUND:
Warm autoimmune hemolytic anemia (WAIHA) is a disorder with a usually good response to corticosteroid treatment, whereas in some cases first-line treatment's response is poor and other therapies such as intravenous immunoglobulins (IVIGs), rituximab, or splenectomy must be applied.
STUDY DESIGN AND METHODS:
Herein, we describe two patients with severe WAIHA treated at our center, who obtained a response after therapeutic plasma exchanges (TPEs) combined with low doses of IVIG.
RESULTS:
The first patient was an 18-year-old man with no relevant past medical history who was diagnosed with WAIHA. The patient presented a progressive clinical worsening despite treatment with prednisone, IVIG, and rituximab. After starting TPEs, signs of hemolysis rapidly improved and hemoglobin started to recover. The second patient was a 38-year-old man with a past history of immune thrombocytopenia and WAIHA. The patient presented a new flare of WAIHA, with no response after 2 weeks of treatment with corticosteroids, IVIG, and rituximab. After initiation of TPEs, the patient had an improvement in hemolysis biomarkers and recovery of hemoglobin concentration.
CONCLUSION:
Combination of TPEs with rituximab and IVIG might be considered as a therapeutic option in patients with severe WAIHA without response to corticosteroid and IVIG treatment.
AuthorsIrene García-García, Joan Cid, Alicia Palomino, Eva Giné, Alberto Alvarez-Larrán, María T Cibeira, Miquel Lozano
JournalTransfusion (Transfusion) Vol. 60 Issue 11 Pg. 2753-2757 (11 2020) ISSN: 1537-2995 [Electronic] United States
PMID33089904 (Publication Type: Case Reports)
Copyright© 2020 AABB.
Chemical References
  • Immunoglobulins, Intravenous
  • Rituximab
Topics
  • Adolescent
  • Adult
  • Anemia, Hemolytic, Autoimmune (blood, diagnosis, therapy)
  • Humans
  • Immunoglobulins, Intravenous (administration & dosage)
  • Male
  • Plasma Exchange
  • Rituximab (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: